  |
|
 |
|
Case Report
| ||||||
| Sigmoid carcinoma: A rare presentation and diagnostic challenge | ||||||
| Bassem Amr1, Komal Munir1, Natasha Santana-Vaz1, Venkateswarlu Velineni1 | ||||||
|
1Worcestershire Acute Hospitals NHS Trust, Woodrow Drive, Redditch, B98 7UB.
| ||||||
| ||||||
|
[HTML Full Text]
[PDF Full Text]
[Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar] 
|
| How to cite this article: |
| Amr B, Munir K, Santana-Vaz N, Velineni V. Sigmoid carcinoma: A rare presentation and diagnostic challenge. International Journal of Case Reports and Images 2013;4(9):477–480. |
|
Abstract
|
|
Introduction:
Adenocarcinoma represents less than 2% of all bladder carcinomas. Metastatic adenocarcinoma is the most common form and usually represents a direct extension from a primary lesion either in the colon, prostate or the female genital organs. Other categories include primary vesical or urachal.
Case Report: We present a case of 79-year-old female presented with microscopic heamaturia, frequency, urgency and weight loss. An adenocarcinoma of the urinary bladder of intestinal origin was founded. Conclusion: Primary adenocarcinoma of the urinary bladder is uncommon neoplasm and the reported incidence of the primary adenocarcinoma is 0.5–2%. It represents a diagnostic challenge raising the inquiry about the site of the lesion. Three major classes were identified: primary vesical adenocarcinoma, urachal adenocarcinoma and extravesical adenocarcinoma involving the bladder. The metastatic adenocarcinoma is the most common category representing a direct extension from a nearby organ or metastatic spread. The most common treatment for urinary bladder adenocarcinoma is surgery. Generally speaking, treatment options include: surgery, radiotherapy, chemotherapy and immunotherapy. Metastatic adenocarcinoma to the urinary bladder especially of colonic origin is of particular interest and need to be ruled out before making a diagnosis of primary adenocarcinoma of urinary bladder. | |
|
Keywords:
Bowel cancer, Adenocarcinoma, Bladder tumor
| |
|
[HTML Full Text]
[PDF Full Text]
|
|
Author Contributions
Bassem Amr – Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Komal Munir – Aquisition of data, Revising it critically for important intellectual content, Final approval of the version to be published Natasha Santana-Vaz – Aquisition of data, Revising it critically for important intellectual content, Final approval of the version to be published Venkateswarlu Velineni – Aquisition of data, Revising it critically for important intellectual content, Final approval of the version to be published |
|
Guarantor of submission
The corresponding author is the guarantor of submission. |
|
Source of support
None |
|
Conflict of interest
Authors declare no conflict of interest. |
|
Copyright
© Bassem Amr et al. 2013; This article is distributed the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any means provided the original authors and original publisher are properly credited. (Please see Copyright Policy for more information.) |
|
|